$JANX
Janux Therapeutics, Inc.
Runway:19+ yrs
NasdaqMarket cap: —CIK 0001817713
Upcoming catalysts
0 surfacedNo catalysts surfaced for JANX yet.
Drug pipeline
Recent & active trials
| NCT | Drug | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT07545811 | JANX014 | Phase 1 | Recruiting | 2028-05-01 |
| NCT05519449 | JANX007 | Phase 1 | Recruiting | 2027-07-01 |
| NCT07291323 | JANX011 | Early Phase 1 | Recruiting | 2026-10-01 |
| NCT05783622 | JANX008 | Phase 1 | Active Not Recruiting | 2026-07-31 |